Focal ST-segment elevation without coronary occlusion: myocardial infarction with no obstructive coronary

Casey Meizinger1, Bruce Klugherz2

  • 1Department of Internal Medicine, Abington Hospital, Jefferson Health Abington, 1200 Old York Road PA, 19118, USA.

Insights

This case report highlights a patient with COVID-19 who experienced myocardial infarction with no obstructive coronary atherosclerosis (MINOCA). It emphasizes that not all myocardial injury in COVID-19 is due to blocked arteries, necessitating further research into cardiovascular complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) is known for respiratory failure but also presents cardiovascular complications.
  • A subset of COVID-19 patients exhibit ST-elevations on ECG with normal coronary angiography, fitting criteria for myocardial infarction with no obstructive coronary atherosclerosis (MINOCA).
  • Non-coronary myocardial injury in COVID-19 patients requires further investigation.

Purpose of the Study:

  • To present a case of COVID-19 associated with MINOCA.
  • To underscore the importance of considering non-obstructive coronary artery disease causes for myocardial injury in COVID-19.
  • To encourage further research into the cardiovascular manifestations of COVID-19.

Main Methods:

  • Case report of an 86-year-old male with acute hypoxic respiratory failure and ECG findings suggestive of myocardial infarction.
  • Initiation of mechanical ventilation and performance of transthoracic echocardiography.
  • Coronary angiography revealing no obstructive coronary artery disease; COVID-19 positivity confirmed.

Main Results:

  • The patient presented with ST-segment elevation on ECG and confirmed COVID-19.
  • Coronary angiography showed no significant coronary artery disease, consistent with MINOCA.
  • Despite intensive care, the patient's outcome was unfavorable.

Conclusions:

  • The presented case suggests a likely association between COVID-19 and MINOCA.
  • It is critical to recognize that myocardial injury in COVID-19 may not stem from obstructive coronary artery disease.
  • Consideration of hypoxic respiratory failure, myocarditis, and systemic inflammation is vital in COVID-19 cardiovascular complications.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...